Mr. Andrew Morris reports
SQI DIAGNOSTICS TO EXHIBIT AT THE NATIONAL BIOTECHNOLOGY CONFERENCE
SQI Diagnostics Inc. will be exhibiting at the American Association of Pharmaceutical Scientists (AAPS) National Biotechnology Conference in San Diego, Calif.
“We are pleased to be a contributor to this very prestigious conference,” said Andrew Morris, chief executive officer of SQI Diagnostics. “This event brings together the world’s leading experts and representatives from all sectors of pharma and biotechnology drug development and gives us the opportunity to share our novel multiplexing applications in drug development testing. Over the past year, we have made significant progress in our work with our pharma and biotech customers and believe our unique products will prove to be beneficial to our customers who are large, global pharmaceutical companies.”
The conference will run from May 1 to May 3, 2017. Please stop by and visit the company at booth 316.
About SQI Diagnostics Inc.
SQI Diagnostics is a life sciences and diagnostics company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics. The company’s proprietary microarray tests and fully automated systems are designed to simplify protein and antibody testing workflow, increase throughput, reduce costs and provide excellent data quality.
We seek Safe Harbor.